US Grants Emergency Use Authorization For Blood Plasma As COVID-19 Treatment

Eurasia Review

23 Aug 2020 0 shares 1 views

US Grants Emergency Use Authorization For Blood Plasma As COVID-19 Treatment

Eurasia Review

Published 23 Aug 2020

By Steve Herman

Calling it “a truly historic announcement,” U.S. President Donald Trump on Sunday hailed a federal government emergency authorization for use of convalescent blood plasma that he declared would “save countless lives” of coronavirus patients.

Trump and his health secretary, Alex Azar, at a...

Full Article

Related news coverage

Global stocks tick higher after 'constructive' US-China trade talks conclude and investors pin hopes on early development of a vaccine

Business Insider 25 Aug 2020

· *Global stocks climbed on Tuesday after the US and China held "constructive" talks about their Phase One trade deal.*
·..

U.S. FDA chief willing to approve a COVID-19 vaccine before Phase 3 trials end
National Post 31 Aug 2020
COVID-19 plasma research well underway in Colorado as Trump fast-tracks wider use
Denver Post 26 Aug 2020
FDA Chief Apologizes For Remarks On COVID-19 Plasma Treatment Benefits
RTTNews 26 Aug 2020
Hospitals and blood banks are running out of convalescent plasma for coronavirus patients — here's how to donate
Business Insider 25 Aug 2020

More coverage

US stocks close at record highs on renewed hopes for fast-tracked virus treatments

Business Insider 24 Aug 2020

· *US equities soared on Monday amid positive news around coronavirus treatments and calming US-China relations.*
· *The..

Travel stocks surge as new COVID cases decline and treatment updates raise hopes for demand rebound

Business Insider

24 Aug 2020

Max Minute: Benefits Of Convalescent Plasma Therapy To COVID-19 Patients Unclear, Despite FDA’s Emergency Use Authorization

CBS 2

24 Aug 2020

FDA, Trump announce emergency use authorization of antibody-rich plasma to treat COVID-19
CBS News 24 Aug 2020
UN cautions that virus plasma treatment still experimental
SeattlePI.com 24 Aug 2020

US Grants Emergency Use Authorization For Blood Plasma As COVID-19 Treatment

US Grants Emergency Use Authorization For Blood Plasma As COVID-19 Treatment

You might like

Related news coverage

Global stocks tick higher after 'constructive' US-China trade talks conclude and investors pin hopes on early development of a vaccine

Advertisement

More coverage

US stocks close at record highs on renewed hopes for fast-tracked virus treatments

Travel stocks surge as new COVID cases decline and treatment updates raise hopes for demand rebound

Max Minute: Benefits Of Convalescent Plasma Therapy To COVID-19 Patients Unclear, Despite FDA’s Emergency Use Authorization